Biofunctional peptides are specific protein fragments that have a positive impact on body functions and conditions and may ultimately influence health peptides modulate physiological function through binding interactions to specific receptors on target cells leading to the induction of physiological responses. Biofunctional peptides are generally 3-20 amino acids residues in length containing potential bioactive sequences from animal and plant source. The most common method of production for Biofunctional peptides is enzymatic hydrolysis. Multiple Biofunctional peptides are produced using trypsin or pepsin. These Biofunctional peptides play an important role in the regulation of the digestive system, immune system, cardiovascular, nervous system and modulation of nutrient absorption. Currently, the market products of Biofunctional peptides contain peptides with satiety including anti-cancer, antimicrobial, stress-relieving properties and others. Biofunctional peptides possess a scientific challenge as they are known to cause optimal exploitation for health benefits. At the same time Biofunctional peptides offer various commercial benefits, owing to which the market of Biofunctional peptides is anticipated to have rapid growth with exceptional CAGR over the forecast period.
Planning to lay down future strategy? Perfect your plan with our report brochure here
Development of Novel Biofunctional Peptides Would Stimulate New Drug Development in Peptide Therapeutics
The synthesis of Biofunctional peptides highly influences the production of multiple antibodies. These peptides are also useful in inventing unique techniques for drug discovery and development and biological research. Various companies and organization store and maintain the peptide library which will help in future to develop various types of vaccines, drugs, amino acid sequencing for research purpose. The rising demand for research and development for early detection and diagnosis of various diseases such as metabolic disorder, cardiovascular disorders, and various genetic disorders. The treatments involving gene therapy can be abundantly supported by developing target specific Biofunctional peptides. Along with increasing healthcare expenditure and an increasing number of clinical trials using Biofunctional peptides are boosting the Biofunctional market globally.
Development of novel technologies, more pieces of evidence of safety and increased knowledge regarding the mechanism and function of peptides will support the growth of the market. Due to the rising demand for potential health benefits, globally the market of Biofunctional peptides is expected to have burgeoning growth. Due to a wide range of applications of Biofunctional peptides, the manufacturers are incorporating peptides as ingredients in the food and dietary supplement. The demand for Biofunctional peptides is expected to grow among the manufacturers of cosmetics and personal care products. Owing to the supportive infrastructure, high acceptance for Biofunctional peptides and rising research activities due to increasing demand is boosting North America to grow as a leader in the Biofunctional peptides market over the globe.
Want to know the obstructions to your company’s growth in future? Request a Custom report here
Biofunctional Peptides Market Segmentation
On the basis of source, the biofunctional peptides market has been segmented as-
On the basis of processing method, the biofunctional peptides market has been segmented as-
- Enzymatic Hydrolysis
- Microbial Fermentation
- Recombinant DNA
- Chemical Synthesis
On the basis of therapeutic area, the biofunctional peptides market has been segmented as-
- Cardiovascular System
- Nervous System
- Gastrointestinal System
- Immune System
- Anti-Diabetic Peptides
- Multifunctional Peptides
On the basis of distribution channel, the biofunctional peptides market has been segmented as-
- Drug Store
- Specialty Store
- Mail Order Pharmacy
- Hospital Pharmacy
- Others (Online Store etc.)
Biofunctional Peptides Market: Key Players
Merck KGaA, Seagarden AS, WN Pharmaceuticals Ltd., Arlak Biotech Pvt. Ltd., Phermpep Co. Ltd., Ashland Inc., ALEXIS Corporation, American Peptide Company Inc., Promega Corporation, Advanced Bioconcept Company, Anaspec Inc. Thermo Fisher Scientific, Novo Nordisk A/S and others.
In 2017, few numbers of new peptide received approval from UDFDA including TRULANCE (Synergy Pharmaceuticals), OZEMPIC (Novo Nordisk), TYMLOS (Radius Health), Parsabiv (Amgen).
Biofunctional Peptides Market Opportunities
The rising cost of research and development in pharmaceutical with a decline in the number of approved drugs has created a demand for an alternative approach to accelerate the R&D activities. To have a profitable market in the highly competitive market, the companies are identifying the opportunity of developing a new drug and new therapies for the treatment of multiple disease and disorders. The Biofunctional peptides are emerging as a unique class of drugs and thus becoming an important part of the pipeline for the biopharmaceutical, pharmaceutical and other industries. The limited production capacity of peptides with specific targets have become a challenge for the industry.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the Biofunctional Peptides market, including but not limited to: regional markets, source, processing method, therapeutic area and distribution channel.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The Biofunctional Peptides market report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the Biofunctional Peptides market report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.